Sara van Kalker

Sara Van Kalker is a highly skilled professional with extensive experience in clinical account management, product development, and market research. Currently serving as a Clinical Account Specialist II at Biosense Webster since August 2020, Sara has also co-founded CTRL, leading product development and market research efforts that significantly increased Alba's valuation. Prior roles include a Market Analyst at Biolocity, where Sara evaluated technologies for improving care in pediatric cardiology, and various research positions at Texas A&M University focused on biorobotics and cancer cell testing. Sara holds a Master’s degree in Biomedical Innovation and Development from Georgia Institute of Technology and a Bachelor's degree from Texas A&M University, complemented by international experience at Universidad de Castilla-La Mancha.